Sutro Biopharma Inc banner

Sutro Biopharma Inc
NASDAQ:STRO

Watchlist Manager
Sutro Biopharma Inc Logo
Sutro Biopharma Inc
NASDAQ:STRO
Watchlist
Price: 25.43 USD 1.8% Market Closed
Market Cap: $410.3m

Cash Flow Statement

Cash Flow Statement
Sutro Biopharma Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Operating Cash Flow
Net Income
(32)
(40)
(49)
(35)
(38)
(40)
(42)
(56)
(61)
(17)
13
(32)
(43)
(79)
(127)
(106)
(114)
(134)
(123)
(119)
(130)
(143)
(172)
(107)
(115)
(124)
(124)
(227)
(245)
(209)
(217)
Depreciation & Amortization
6
5
5
5
5
5
5
5
5
5
4
4
4
5
5
5
5
5
5
6
6
6
7
7
7
7
7
7
7
7
8
Stock-Based Compensation
2
2
2
3
5
7
10
10
11
11
12
12
13
16
19
23
26
27
27
26
25
25
25
25
25
24
25
25
23
22
18
Other Non-Cash Items
5
3
3
1
2
5
7
9
10
(35)
(63)
(28)
(16)
30
62
37
29
38
35
13
17
3
10
23
19
29
8
20
27
35
58
Cash Taxes Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
15
15
18
18
3
3
Cash Interest Paid
1
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
1
2
1
1
1
0
0
0
0
0
0
Change in Working Capital
(31)
(3)
55
43
38
36
(27)
(23)
(17)
(12)
(16)
(11)
(25)
(28)
(19)
(18)
(6)
7
88
104
85
83
7
(34)
(27)
14
3
9
16
(83)
(71)
Cash from Operating Activities
(52)
N/A
(36)
+31%
14
N/A
13
-8%
8
-41%
6
-22%
(58)
N/A
(65)
-12%
(64)
+2%
(61)
+5%
(62)
-3%
(68)
-9%
(80)
-17%
(72)
+9%
(79)
-9%
(82)
-3%
(87)
-6%
(84)
+2%
6
N/A
4
-39%
(22)
N/A
(50)
-126%
(150)
-198%
(112)
+25%
(115)
-3%
(74)
+35%
(106)
-42%
(192)
-81%
(195)
-2%
(250)
-28%
(223)
+11%
Investing Cash Flow
Capital Expenditures
(4)
(2)
(1)
(2)
(1)
(2)
(2)
(3)
(4)
(5)
(8)
(7)
(9)
(12)
(14)
(15)
(14)
(11)
(7)
(8)
(7)
(7)
(6)
(4)
(4)
(3)
(3)
(3)
(4)
(3)
(3)
Other Items
36
9
(79)
(79)
(156)
(147)
(55)
(48)
73
8
0
8
(154)
(87)
(88)
(82)
72
111
31
(27)
7
24
(12)
0
(3)
(151)
111
222
142
225
117
Cash from Investing Activities
32
N/A
7
-77%
(81)
N/A
(80)
+0%
(158)
-97%
(149)
+6%
(57)
+62%
(51)
+10%
69
N/A
2
-97%
(7)
N/A
1
N/A
(163)
N/A
(100)
+39%
(102)
-3%
(97)
+5%
57
N/A
99
+73%
24
-76%
(35)
N/A
(1)
+98%
18
N/A
(18)
N/A
(4)
+79%
(7)
-85%
(154)
-2 012%
107
N/A
219
+103%
139
-37%
221
+60%
114
-48%
Financing Cash Flow
Net Issuance of Common Stock
15
48
85
170
170
136
85
0
1
92
110
255
256
165
149
2
1
10
42
58
69
62
30
12
1
97
97
99
98
1
0
Net Issuance of Debt
0
0
0
0
(1)
(2)
(4)
(5)
11
12
14
15
0
0
0
0
0
(3)
(6)
(9)
(13)
(13)
(13)
(13)
(13)
(10)
(7)
(4)
0
0
0
Other
(1)
(1)
(2)
1
1
2
4
1
0
0
(1)
(0)
(1)
(1)
(1)
1
1
1
1
(0)
(0)
139
136
138
138
(2)
2
(1)
(0)
(0)
(0)
Cash from Financing Activities
15
N/A
47
+224%
83
+75%
171
+106%
170
0%
137
-20%
85
-38%
(4)
N/A
12
N/A
104
+770%
123
+18%
269
+120%
255
-5%
164
-36%
148
-10%
3
-98%
2
-33%
8
+253%
37
+374%
48
+32%
56
+17%
188
+235%
153
-19%
138
-10%
125
-9%
84
-33%
91
+8%
94
+3%
97
+4%
1
-99%
0
-89%
Change in Cash
Net Change in Cash
(5)
N/A
19
N/A
16
-16%
103
+548%
20
-81%
(6)
N/A
(29)
-387%
(120)
-309%
17
N/A
46
+171%
53
+16%
202
+279%
13
-94%
(8)
N/A
(34)
-316%
(176)
-422%
(27)
+85%
23
N/A
66
+191%
17
-75%
34
+99%
156
+364%
(15)
N/A
22
N/A
3
-88%
(144)
N/A
92
N/A
121
+31%
41
-66%
(27)
N/A
(108)
-297%
Free Cash Flow
Free Cash Flow
(56)
N/A
(38)
+32%
12
N/A
11
-10%
6
-46%
4
-35%
(60)
N/A
(69)
-14%
(68)
+1%
(66)
+3%
(70)
-6%
(75)
-8%
(88)
-18%
(85)
+4%
(93)
-10%
(97)
-4%
(101)
-4%
(96)
+5%
(1)
+99%
(4)
-262%
(29)
-583%
(57)
-93%
(156)
-174%
(116)
+26%
(119)
-3%
(77)
+35%
(109)
-41%
(195)
-78%
(199)
-2%
(253)
-27%
(225)
+11%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett